Published in J Neuroeng Rehabil on May 27, 2014
Self-selected gait speed--over ground versus self-paced treadmill walking, a solution for a paradox. J Neuroeng Rehabil (2015) 0.82
Validity of the Kinect for Gait Assessment: A Focused Review. Sensors (Basel) (2016) 0.81
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J (2016) 0.79
Automated extraction and validation of children's gait parameters with the Kinect. Biomed Eng Online (2015) 0.78
Accuracy and Reliability of the Kinect Version 2 for Clinical Measurement of Motor Function. PLoS One (2016) 0.77
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis. PLoS One (2016) 0.75
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability. J Neural Transm (Vienna) (2016) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Multiple sclerosis. N Engl J Med (2000) 12.69
Accuracy and resolution of Kinect depth data for indoor mapping applications. Sensors (Basel) (2012) 11.17
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler (1999) 3.71
Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology (1990) 2.24
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler (2006) 1.95
Validity of the Microsoft Kinect for assessment of postural control. Gait Posture (2012) 1.72
Quantification of walking mobility in neurological disorders. QJM (2004) 1.67
Passive in-home measurement of stride-to-stride gait variability comparing vision and Kinect sensing. Conf Proc IEEE Eng Med Biol Soc (2011) 1.30
Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler (2005) 1.13
Quantifying gait impairment in multiple sclerosis using GAITRite technology. Gait Posture (2011) 1.13
Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS. Neurology (2013) 1.10
Gait variability in people with multiple sclerosis. Mult Scler (2006) 1.09
Perception of lower limb spasticity in patients with spinal cord injury. Spinal Cord (2008) 1.08
Full body gait analysis with Kinect. Conf Proc IEEE Eng Med Biol Soc (2012) 1.05
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors. Mult Scler (2013) 1.02
Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler (2011) 1.02
Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture (2012) 0.99
The reliability of the MSFC and its components. Acta Neurol Scand (2007) 0.94
Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment. Exp Brain Res (2011) 0.92
Accuracy of Kinect's skeleton tracking for upper body rehabilitation applications. Disabil Rehabil Assist Technol (2013) 0.91
EDSS reliability. Neurology (1991) 0.91
Muscular and gait abnormalities in persons with early onset multiple sclerosis. J Neurol Phys Ther (2011) 0.90
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis. PLoS One (2012) 0.90
Model-based reinforcement of Kinect depth data for human motion capture applications. Sensors (Basel) (2013) 0.88
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA J (2012) 0.87
Gait variability and multiple sclerosis. Mult Scler Int (2013) 0.85
Balance recovery through virtual stepping exercises using Kinect skeleton tracking: a follow-up study with chronic stroke patients. Stud Health Technol Inform (2012) 0.83
Capturing habitual, in-home gait parameter trends using an inexpensive depth camera. Conf Proc IEEE Eng Med Biol Soc (2012) 0.82
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. NeuroRehabilitation (2012) 0.81
Multiple sclerosis spasticity: 'state-of-the-art' questionnaire survey of specialized healthcare professionals. Expert Rev Neurother (2013) 0.80
[Spasticity and everyday life in multiple sclerosis]. Rev Neurol (Paris) (2012) 0.78
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes. NeuroRehabilitation (2012) 0.77
Photoreceptor layer thinning in idiopathic Parkinson's disease. Mov Disord (2014) 3.36
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol (2011) 1.73
Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2013) 1.42
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS One (2012) 1.41
Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One (2011) 1.35
Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg (2010) 1.30
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler (2013) 1.30
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25
Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int (2012) 1.24
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler (2012) 1.23
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PLoS One (2013) 1.18
Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One (2011) 1.14
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One (2013) 1.13
Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. Brain (2009) 1.11
Expanding two-photon intravital microscopy to the infrared by means of optical parametric oscillator. Biophys J (2010) 1.10
Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One (2011) 1.06
In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity. J Neuroinflammation (2011) 0.99
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study. Mult Scler (2012) 0.98
MRI pattern recognition in multiple sclerosis normal-appearing brain areas. PLoS One (2011) 0.94
New insights into adaptive immunity in chronic neuroinflammation. Adv Immunol (2007) 0.92
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study. Eur Radiol (2014) 0.90
Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler (2010) 0.89
Is metabolic flexibility altered in multiple sclerosis patients? PLoS One (2012) 0.87
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis. BMC Neurol (2014) 0.84
Dynamics of saccade parameters in multiple sclerosis patients with fatigue. J Neurol (2012) 0.83
Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS One (2012) 0.83
Geranylgeranylation but not GTP loading determines rho migratory function in T cells. J Immunol (2007) 0.79
Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency. J Neurol (2015) 0.76
Author response. Neurology (2015) 0.75
Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1. Cerebellum (2014) 0.75
Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers. Neuropsychobiology (2014) 0.75